Regimen Wealth’s Johnson & Johnson JNJ Stock Holding History

Regimen Wealth’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,232	Closed	-$218K	–	69
2022 Q4	$218K	Buy	+1,232	New	+$213K	0.15%	51

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Regimen Wealth's JNJ Position: Q1 2023 in Review

Regimen Wealth sold out of Johnson & Johnson (JNJ) in Q1 2023, closing a stake of 1,232 shares — an estimated $218K sold.

Regimen Wealth first reported a position in JNJ in Q4 2022 and held it in 1 quarter. The position peaked at $218K in Q4 2022. 3,729 funds tracked by Wall St. Rank hold JNJ as of Q1 2023.

Regimen Wealth reported no remaining Johnson & Johnson position as of Q1 2023 after selling out during the quarter.
Regimen Wealth sold 1,232 Johnson & Johnson shares in Q1 2023, an estimated $218K.
Regimen Wealth first reported a position in Johnson & Johnson in Q4 2022 and held it in 1 quarter.
Regimen Wealth's Johnson & Johnson position peaked at $218K in Q4 2022.
3,729 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2023.

Based on Regimen Wealth's 13F filing for Q1 2023, filed 5 May 2023.